2. Signaling Pathways
  3. Others
  4. Drug Intermediate

Drug Intermediate

Drug Iintermediate

Drug intermediates are used as raw materials for the production of bulk drugs, or they can refer to a material produced during synthesis of an API that must undergo further molecular change or processing before it becomes an API. Drug intermediates are hygienically formulated using high grade raw materials and they are used in the pharmaceutical and cosmetic industry[1][2].

Drug Intermediate Related Products (4365):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-101427
    Bamaquimast
    		98.97%
    Bamaquimast (F 10126) is an anti-asthmatic agent and mediator release inhibitor. Bamaquimast can be used in the research of chronic obstructive bronchopulmonary disease.
    Bamaquimast
  • HY-P5025
    Cyclo(Arg-Gly-Asp-D-Tyr-ε-azido-Nle)
    		99.16%
    Cyclo(Arg-Gly-Asp-D-Tyr-ε-azido-Nle) (Azido-c(RGDyK)) is a polypeptide composed of arginine, glycine, aspartic acid, and tyrosine that can be used for Synthesis of [18F]FPyKYNE-c(RGDyK).
    Cyclo(Arg-Gly-Asp-D-Tyr-ε-azido-Nle)
  • HY-78139S1
    L-Xylose-2-13C
    		99.0%
    L-Xylose-2-13C ((L-(-)-Xylose-2-13C)) is the 13C labeled L-Xylose (HY-78139). L-Xylose (L-(-)-Xylose) is a rare sugar and the levorotatory form of Xylose (HY-N0537). L-Xylose can be used as a raw material for the synthesis of various drugs and bioactive molecules.
    L-Xylose-2-<sup>13</sup>C
  • HY-145800
    Photocaged DAP TFA
    		99.86%
    Photocaged DAP (pm-DAP) TFA is a protected version of 2,3-Diaminopropionic acid (DAP) (HY-W013673). Photocaged DAP TFA can produce 2,3-Diaminopropionic acid after photodeprotection. Photocaged DAP TFA can be used as an intermediate to capture biosynthetic acylase.
    Photocaged DAP TFA
  • HY-133994
    Octakis-(6-bromo-6-deoxy)-γ-cyclodextrin
    		99.73%
    Octakis-(6-bromo-6-deoxy)-γ-cyclodextrin is a perbrominated γ-cyclodextrin at the primary side. Octakis-(6-bromo-6-deoxy)-γ-cyclodextrin is also a commonly used intermediate in the modification of cyclodextrin.
    Octakis-(6-bromo-6-deoxy)-γ-cyclodextrin
  • HY-W010321
    Furfuryl acetate
    		98.30%
    Furfuryl acetate can be used in the synthesis of 5-acetoxymethyl-2-vinylfuran and 5-hydroxymethyl-2-vinylfuran.
    Furfuryl acetate
  • HY-N7130
    Thioisonicotinamide
    		99.82%
    Thioisonicotinamide (4-Pyridylthioamide) is a synthetic intermediate used for pharmaceutical synthesis.
    Thioisonicotinamide
  • HY-19856
    Valnivudine hydrochloride
    		98.99%
    FV-100 is a potent, selective and orally active anti-varicella zoster virus agent. FV-100 is a proagent of CF-1743. FV-100 exhibits very low toxicity in vivo.
    Valnivudine hydrochloride
  • HY-W010589S
    L-2-Aminobutyric acid-d3
    		99.9%
    L-2-Aminobutyric acid-d3 is the deuterium labeled L-2-Aminobutyric acid. L-2-Aminobutyric acid is a non-proteinogenic amino acid that exists in human tissues and body fluids. L-2-Aminobutyric acid is formed by the transamination of oxobutyric acid. L-2-Aminobutyric acid can serve as a precursor for anticonvulsant and anti-tuberculosis agents and is a key intermediate in the chemical and pharmaceutical industries.
    L-2-Aminobutyric acid-d<sub>3</sub>
  • HY-117289
    AKOS B018304
    		99.37%
    AKOS B018304 is an arylalkylidene derivative, with polar substitution at para-position.
    AKOS B018304
  • HY-117702
    RB 101
    RB 101 is a blood-brain barrier-crossing prodrug as well as aminopeptidase N and neutral endopeptidase-24.11 inhibitor. RB 101 blocks enkephalin breakdown, elevates extracellular enkephalin levels and activate δ-opioid receptor and dopamine D1 receptor. RB 101 can be used for the research of pain, depressive syndromes, and diabetic neuropathy.
    RB 101
  • HY-178271
    P-SCN-Bn-NOTA
    P-SCN-Bn-NOTA is a metal chelator and molecular imaging probe precursor that allows radiolabeling with Ga-68. P-SCN-Bn-NOTA can be conjugated to CD70-specific molecules B3, B6, ABDB3 and ABDB6 to form NOTA-labeled derivatives. P-SCN-Bn-NOTA is applicable for preclinical PET/CT imaging of CD70-expressing tumors in NCG mouse PDX models. P-SCN-Bn-NOTA can be used in studies related to CD70-positive tumors.
    P-SCN-Bn-NOTA
  • HY-177928
    Adavosertib acid
    Adavosertib (AZD1775; MK-1775) acid (Compound 9) is a derivative of AZD1775 (HY-10993) and can be used for the synthesis of PROTAC.
    Adavosertib acid
  • HY-402737
    FTC-146 precursor
    FTC-146 precursor (Compound s6) is a drug intermediate that can be used to prepare σ-1 receptor positron emission tomography tracers ([¹⁸F]FTC-146).
    FTC-146 precursor
  • HY-W008187
    4-Fluoro-3-nitrobenzaldehyde
    		99.77%
    4-Fluoro-3-nitrobenzaldehyde is a biochemical reagent that can be used as a biological material or organic compound for life science related research. 4-Fluoro-3-nitrobenzaldehyde is also a pharmaceutical intermediate and can be used in the synthesis of other active compounds.
    4-Fluoro-3-nitrobenzaldehyde
  • HY-B2062R
    Chlorthal-dimethyl (Standard)
    Chlorthal-dimethyl (Standard) is the analytical standard of Chlorthal-dimethyl. This product is intended for research and analytical applications. Chlorthal-dimethyl (Dimethyl tetrachloroterephthalate) is a plant growth regulator. Chlorthal-dimethyl affects cell division and differentiation, interfering with the normal development of vascular tissue. Chlorthal-dimethyl causes localized swelling of tomato hypocotyls and disrupts normal mitosis in germinating millet seedlings.
    Chlorthal-dimethyl (Standard)
  • HY-133970S
    5α-Cholestane-d6
    		99.78%
    5α-Cholestane-d6 is the deuterium labeled 5α-Cholestane (HY-133970). 5α-Cholestane is a skeleton. 5α-Cholestane can be used in the synthesis of Brassinosteroids. 5α-Cholestane can be used in skeletal muscle research.
    5α-Cholestane-d<sub>6</sub>
  • HY-16031
    AFP464 free base
    AFP464 (NSC710464) free base is a prodrug of Aminoflavone (HY-132974) and an agonist of the aryl hydrocarbon receptor (AhR). AFP464 free base downregulates the expression of α6-integrin (α6-integrin), inhibits breast tumor growth, reduces the population of tumor-initiating cells, disrupts mammosphere structure, induces the formation of mucin lake clusters, triggers DNA damage, and exerts antiproliferative activity. AFP464 free base is rapidly converted to Aminoflavone by nonspecific esterases in plasma and cell culture media. AFP464 free base is applicable to research related to breast cancer.
    AFP464 free base
  • HY-W130232
    Diformylphloroglucinol
    		99.58%
    Diformylphloroglucinol is an acylphloroglucinol compound that can be used in the synthesis of Psiguadial B. Psiguadial B is a neuroprotective agent.
    Diformylphloroglucinol
  • HY-48306
    G-814 intermediate-1
    G-814 intermediate-1 (compound 9) is an intermediate in the synthesis of G-814. G-814 intermediate-1 can be used for the synthesis of ADCs.
    G-814 intermediate-1